Prior to joining medicxi, Alasdair was an Associate with Index Ventures for two years. In this role, he worked on and completed a number of investments including Morphogen-IX, Stealthyx, Z-factor, and Epsilon-3 Bio. Prior to that, he gained experience with three healthcare startups in strategy and business development roles.
Alasdair graduated with a MPhil in Bioscience Enterprise from the University of Cambridge and a BA (Hons) in Law and Chinese from the School of Oriental and African Studies, University of London. He also spent time studying Chinese at Fudan University in Shanghai and Beijing Normal University.